Skip to main content

Fiscal Wizard · Single-issue tearsheet

ELV / Jun 21, 2026 Run #7487

ELV

Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Composite verdict

B 74.5 / 100
Bullish setup · Mean Reversion 10 drivers · 2 gates blocking
  • Williams %R
  • Double 7s
  • Connors RSI(2)
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 3rd of 11 in Healthcare Plans

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 17 signals0% Bear
Momentum Bullish 79Mean-reversion Bullish 69
  • Pullback buyOversold in an uptrend — a pullback buy: mean-reversion aligned with the primary trend, the high-value case for an oversold signal. (medium confidence)
Where value comes fromMargin of safety -44%
Asset value $202.07Earnings power value $207.58Price $388.50

Priced above its no-growth earnings power value ($207.58/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

49.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 100
Margin of Safety 0
Greenblatt ROC 76
EPS Growth (YoY) 0
Return on Assets 76
Cash Conversion 12

Technicals Bullish

99.9 / 100

Bullish setup leads (Williams %R, Double 7s, Connors RSI(2)); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 93
Double 7s 85
Connors RSI(2) 82

Risk Gates

2 blocking 8 caution

2 guards active, 25 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ELV.